{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T01:57:53Z","timestamp":1794880673337,"version":"4.9.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:p>\n                    We report the first administration of an orally active aldosterone synthase inhibitor, LCI699, to 14 patients with primary aldosteronism. After a 2-week placebo run-in, patients received oral LCI699 (0.5 mg BID) for 2 weeks, LCI699 (1.0 mg BID) for 2 weeks, and placebo for 1 week. We assessed changes in hormone concentrations, plasma potassium levels, and 24-hour ambulatory systolic blood pressure and safety. The supine plasma aldosterone concentration decreased from 540 pmol\/L (95% CI: 394 to 739 pmol\/L) to 171 pmol\/L (95% CI: 128 to 230 pmol\/L) after 0.5 mg of LCI699 (\u221268%;\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.0001) and to 133 pmol\/L (95% CI: 100 to 177 pmol\/L) after 1.0 mg of LCI699 (\u221275%;\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.0001). Plasma 11-deoxycorticosterone concentrations increased by 710% after 0.5 mg of LCI699 (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.0001) and by 1427% after 1.0 mg of LCI699 (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.0001). The plasma potassium concentration increased from 3.27\u00b10.31 to 4.03\u00b10.33 mmol\/L (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.0001) after only 1 week on 0.5 mg of LCI699. Twenty-four\u2013hour ambulatory systolic blood pressure decreased by \u22124.1 mm Hg (95% CI: \u22128.1 to \u22120.1 mm Hg) after 4 weeks of treatment (\n                    <jats:italic>P<\/jats:italic>\n                    =0.046). Basal plasma cortisol concentrations remained unchanged, whereas plasma adrenocorticotropic hormone concentrations increased by 35% after 0.5 mg of LCI699 (\n                    <jats:italic>P<\/jats:italic>\n                    =0.08) and by 113% after 1.0 mg of LCI699 (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.0001), and the plasma cortisol response to an adrenocorticotropic hormone test was blunted. All of the variables except plasma 11-deoxycorticosterone concentration returned to initial levels after the placebo. LCI699 was well tolerated. In conclusion, the administration of LCI699, up to 1.0 mg BID, effectively and safely inhibits aldosterone synthase in patients with primary aldosteronism. This 4-week treatment corrected the hypokalemia and mildly decreased blood pressure. The effects on the glucocorticoid axis were consistent with a latent inhibition of cortisol synthesis.\n                  <\/jats:p>","DOI":"10.1161\/hypertensionaha.110.157271","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T01:00:48Z","timestamp":1284426048000},"page":"831-838","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":195,"title":["Aldosterone Synthase Inhibition With LCI699"],"prefix":"10.1161","volume":"56","author":[{"given":"Laurence","family":"Amar","sequence":"first","affiliation":[{"name":"From the Universite\u0301 Paris Descartes (L.A., M.A., J.M., S.P., P.-F.P.), Faculte\u0301 de Me\u0301decine, Paris, France; Assistance Publique des Ho\u0302pitaux de Paris (L.A., M.A., J.M., S.P.), Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France; Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (L.A., M.A., J.M., S.P., P.-F.P.), Clinical Investigation Centre 9201, Paris, France; Novartis Pharmaceuticals (C.W.), East Hanover, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Azizi","sequence":"additional","affiliation":[{"name":"From the Universite\u0301 Paris Descartes (L.A., M.A., J.M., S.P., P.-F.P.), Faculte\u0301 de Me\u0301decine, Paris, France; Assistance Publique des Ho\u0302pitaux de Paris (L.A., M.A., J.M., S.P.), Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France; Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (L.A., M.A., J.M., S.P., P.-F.P.), Clinical Investigation Centre 9201, Paris, France; Novartis Pharmaceuticals (C.W.), East Hanover, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe\u0308l","family":"Menard","sequence":"additional","affiliation":[{"name":"From the Universite\u0301 Paris Descartes (L.A., M.A., J.M., S.P., P.-F.P.), Faculte\u0301 de Me\u0301decine, Paris, France; Assistance Publique des Ho\u0302pitaux de Paris (L.A., M.A., J.M., S.P.), Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France; Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (L.A., M.A., J.M., S.P., P.-F.P.), Clinical Investigation Centre 9201, Paris, France; Novartis Pharmaceuticals (C.W.), East Hanover, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se\u0301verine","family":"Peyrard","sequence":"additional","affiliation":[{"name":"From the Universite\u0301 Paris Descartes (L.A., M.A., J.M., S.P., P.-F.P.), Faculte\u0301 de Me\u0301decine, Paris, France; Assistance Publique des Ho\u0302pitaux de Paris (L.A., M.A., J.M., S.P.), Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France; Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (L.A., M.A., J.M., S.P., P.-F.P.), Clinical Investigation Centre 9201, Paris, France; Novartis Pharmaceuticals (C.W.), East Hanover, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Watson","sequence":"additional","affiliation":[{"name":"From the Universite\u0301 Paris Descartes (L.A., M.A., J.M., S.P., P.-F.P.), Faculte\u0301 de Me\u0301decine, Paris, France; Assistance Publique des Ho\u0302pitaux de Paris (L.A., M.A., J.M., S.P.), Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France; Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (L.A., M.A., J.M., S.P., P.-F.P.), Clinical Investigation Centre 9201, Paris, France; Novartis Pharmaceuticals (C.W.), East Hanover, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Franc\u0327ois","family":"Plouin","sequence":"additional","affiliation":[{"name":"From the Universite\u0301 Paris Descartes (L.A., M.A., J.M., S.P., P.-F.P.), Faculte\u0301 de Me\u0301decine, Paris, France; Assistance Publique des Ho\u0302pitaux de Paris (L.A., M.A., J.M., S.P.), Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France; Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (L.A., M.A., J.M., S.P., P.-F.P.), Clinical Investigation Centre 9201, Paris, France; Novartis Pharmaceuticals (C.W.), East Hanover, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_1_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mnh.0000165889.60254.98"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-005-2343-3"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.03.004"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000230444.01215.6a"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000230482.82239.a0"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2007-0030"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2008.10.029"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033263"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1088"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2521"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030207"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000044937.95080.e9"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00701.x"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00240106"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(87)91030-7"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1039"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-69-4-896"},{"key":"e_1_3_3_19_2","first-page":"571","volume":"74","year":"1992","unstructured":"Trunet PF, Mueller P, Girard F, Aupetit B, Bhatnagar AS, Zognbi F, Ezzet F, Menard J. The effects of fadrozole hydrochloride on aldosterone secretion in healthy male subjects. J Clin Endocrinol Metab. 1992; 74: 571\u2013576.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.104.521625"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000226205.65442.f2"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn277"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.9"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.90903.2008"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(10)60584-0"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.07.059"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-198308000-00014"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283060f0c"},{"key":"e_1_3_3_29_2","unstructured":"Menard J Bellet M Brunner HR. Clinical development of antihypertensive drugs. In: Laragh JH Brenner BM eds. Hypertension. Pathophysiology Diagnosis and Management. Vol 2. New York NY: Raven Press; 1995: 3049\u20133063."},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200018040-00006"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp030057"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2009.07.025"},{"key":"e_1_3_3_33_2","unstructured":"Baxter JD Blake Tyrrell J. The adrenal cortex. In: Felig P Baxter JD Broadus AE Frohman LA eds. Endocrinology and Metabolism. New York NY: McGraw-Hill Inc; 1987: 511\u2013650."},{"key":"e_1_3_3_34_2","unstructured":"Orth DN Kowacs WJ DeBold CR. The adrenal cortex. In: Wilson JD Foster DW eds. Williams Texbook of Endocrinology. Philadelphia PA: WB Saunders Company; 1992: 489\u2013620."},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032149"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.167148"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-1102"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(10)60583-9"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.109.149062"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.110.157271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:54:09Z","timestamp":1715576049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.110.157271"}},"subtitle":["A Proof-of-Concept Study in Patients With Primary Aldosteronism"],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.110.157271"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.110.157271","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"2010-06-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-08-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-09-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}